TSLP与IL-33/ST2在变应性鼻炎中的协同作用及缺氧影响
该研究以大鼠鼻黏膜上皮细胞为对象,在缺氧与常氧条件下培养,通过敲低TSLP和阻断IL-33观察两条通路的相互作用。结果显示变应性鼻炎大鼠鼻黏膜上皮细胞中TSLP、IL-33和ST2表达显著升高,缺氧进一步促进其表达,且TSLP与IL-33/ST2存在协同作用。
要点
- 变应性鼻炎大鼠鼻黏膜上皮细胞中TSLP、IL-33、ST2表达显著高于对照。
- 缺氧进一步促进TSLP、IL-33/ST2表达并增强促增殖、抗凋亡和促迁移效应。
- 敲低TSLP可减弱IL-33/ST2轴表达,阻断IL-33也可降低TSLP表达。
核心结论
- TSLP与IL-33/ST2信号通路在变应性鼻炎的发病和病理发展中相互作用。
- 抑制TSLP是变应性鼻炎治疗的关键因素。
- 抑制缺氧诱导的病理过程可能通过下调TSLP来抑制IL-33/ST2表达,从而产生治疗效应。
研究设计与样本
- 研究获取Wistar大鼠鼻黏膜上皮细胞,在缺氧和常氧条件下分组培养。
- 通过免疫组化和免疫荧光鉴定大鼠鼻上皮细胞及蛋白表达。
- 使用CCK-8和Transwell试剂盒检测细胞增殖和迁移,荧光凋亡试剂盒检测凋亡。
- 采用ELISA和Western blot检测细胞分泌和蛋白表达。
- 通过慢病毒转染敲低TSLP,并使用IL-33拮抗剂阻断IL-33。
主要发现
- 变应性鼻炎大鼠鼻黏膜上皮细胞中TSLP、IL-33和ST2表达显著高于对照大鼠。
- 缺氧进一步促进TSLP、IL-33和ST2的表达。
- TSLP和IL-33/ST2表达增加促进细胞增殖、抑制细胞凋亡并增强细胞迁移。
- 下调TSLP表达有效减弱IL-33/ST2轴表达,使用IL-33拮抗剂也可降低TSLP表达,协同效应在缺氧下更明显。
临床怎么用
- TSLP抑制可能是变应性鼻炎治疗的关键靶点。
- 针对缺氧诱导的病理过程进行干预,可能通过下调TSLP抑制IL-33/ST2表达而发挥治疗作用。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The World Health Organization (WHO) has noted that allergic diseases are a major health problem of the 21st century. Allergic rhinitis (AR) is a type I allergic disease characterized by nasal mucosa and immune system abnormalities. AR is mediated by various inflammatory cells and is mainly characterized by altered secretion of cytokines. Thymic stromal lymphopoietin (TSLP) and the interleukin-33/stimulation-expressed gene 2 (IL-33/ST2) signaling pathway are cytokines that play pivotal roles in many inflammatory responses and allergic reactions. There have been reports of interactions between the 2 pathways in many diseases. Hypoxia is a common pathologic manifestation of AR. The aim of this study was to explore the relationship and expressions and biologic functions of TSLP and IL-33/ST2 in AR, and also to determine the effects of hypoxia on these cytokines. METHODS: The rat nasal mucosal epithelium was obtained from Wistar rats. Cells were cultured in groups under hypoxia and normoxia conditions. Identification of rat nasal epithelial cell (RNEpC) and protein expressions was done by immunohistochemistry and immunofluorescence methods. Cell proliferation and migration were examined using the cell counting kit-8 (CCK-8) and Transwell kit. Detection of apoptosis was tested using a fluorescence apoptosis kit. Enzyme-linked immunoassay (ELISA) and Western blot analysis ELISA were used to measure cell secretion and protein expressions. For these experiments, TSLP was knocked down by lentivirus transfection and IL-33 blocked with its antagonist. RESULTS: TSLP, IL-33, and ST2 expressions were significantly higher in nasal mucosa epithelial cells from AR rats than in those from control rats. Hypoxia further promoted their expression. Increased TSLP and IL-33/ST2 promoted cell proliferation, inhibited cell apoptosis, and enhanced cell migration. In addition, the downregulation of TSLP expression effectively attenuated expression of the IL-33/ST2 axis and, through use of IL-33 antagonists, could also reduce TSLP expression, a synergistic effect more obvious under hypoxia. CONCLUSION: Our data indicate that TSLP and IL-33/ST2 signaling pathways interact with each other in the pathogenesis and pathologic development of AR. TSLP inhibition is a key factor in AR treatment. Inhibiting hypoxia-induced pathologic processes could represent a therapeutic effect by inhibiting IL-33/ST2 expression via downregulating TSLP.
引用
- Huang R, Mao W, Wang G, et al. Synergistic relationship between TSLP and IL-33/ST2 signaling pathways in allergic rhinitis and the effects of hypoxia. Int Forum Allergy Rhinol. 2020. PMID: 31922361. doi:10.1002/alr.22504
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。